Celldex Therapeutics CLDX
NASDAQ CLDX
$32.18 -0.23 (-0.71%)
At close: Oct 1, 2026 · 4:00 PM EDT

Celldex Therapeutics (CLDX) Shares Outstanding (Diluted) (2010 - 2026)

Updated

Celldex Therapeutics (CLDX) recorded Shares Outstanding (Diluted) of 77.84 million in Q2 2026, up 17.2% from 66.39 million a year earlier and up 16.9% from the prior quarter.

Analysis

Celldex Therapeutics (CLDX) Shares Outstanding (Diluted) (2010 - 2026) Analysis & Trends

For FY2025, Celldex Therapeutics reported Shares Outstanding (Diluted) of 66.42 million, up 3.1% from FY2024.

  • Annual Shares Outstanding (Diluted) has increased for seven straight years, with a five-year compound annual growth rate of 17.5% (FY2020 to FY2025).
  • Across earlier years, Shares Outstanding (Diluted) came in at 64.4 million in FY2024 (+32.9%), 48.45 million in FY2023 (+3.3%), 46.89 million in FY2022 (+9.4%) and 42.87 million in FY2021 (+44.6%).
  • The Q2 2026 figure is the highest quarterly Shares Outstanding (Diluted) in data going back to Q2 2010.
  • On a year-over-year basis, Shares Outstanding (Diluted) has increased for 27 consecutive quarters, with growth averaging 13.4% over the last eight quarters.
  • Over the past five years, the year-over-year growth in Shares Outstanding (Diluted) ranged from 0.2% (Q3 2025) to 213.3% (Q3 2021).
  • Per Business Quant, the preceding three quarters came in at 66.57 million (Q1 2026), 66.42 million (Q4 2025) and 66.42 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.44 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 1.96 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.56 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 544.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 255.20 Mn
10 Celldex Therapeutics 2.54 Bn 2.54 Bn - 77.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 77.84 Mn
Mar 31, 2026 66.57 Mn
Dec 31, 2025 66.42 Mn
Sep 30, 2025 66.42 Mn
Jun 30, 2025 66.39 Mn
Mar 31, 2025 66.38 Mn
Dec 31, 2024 64.40 Mn
Sep 30, 2024 66.29 Mn
Jun 30, 2024 66.02 Mn
Mar 31, 2024 58.87 Mn
Dec 31, 2023 48.45 Mn
Sep 30, 2023 47.26 Mn
Jun 30, 2023 47.25 Mn
Mar 31, 2023 47.21 Mn
Dec 31, 2022 46.89 Mn
Sep 30, 2022 46.92 Mn
Jun 30, 2022 46.76 Mn
Mar 31, 2022 46.74 Mn
Dec 31, 2021 42.87 Mn
Sep 30, 2021 45.45 Mn
API Access

Celldex Therapeutics Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=CLDX&period=max&api_key=YOUR_API_KEY